Challenges of research on treatment-resistant depression: a clinician's perspective.
作者信息
Rush A John
机构信息
Duke-National University of Singapore, Singapore; Duke Medical School, Durham, NC, USA.
出版信息
World Psychiatry. 2023 Oct;22(3):415-417. doi: 10.1002/wps.21136.
Abstract
摘要
相似文献
1
Challenges of research on treatment-resistant depression: a clinician's perspective.难治性抑郁症的研究挑战：临床医生视角
World Psychiatry. 2023 Oct;22(3):415-417. doi: 10.1002/wps.21136.
2
Relationship Between Gender and Clinician's Subjective Experience during the Interaction with Psychiatric Patients.性别与临床医生在与精神科患者互动过程中的主观体验之间的关系。
Clin Pract Epidemiol Ment Health. 2021 Dec 22;17:190-197. doi: 10.2174/1745017902117010190. eCollection 2021.
3
Association between Clinician's Subjective Experience during Patient Evaluation and Psychiatric Diagnosis.患者评估期间临床医生的主观体验与精神科诊断之间的关联
Psychopathology. 2016;49(2):83-94. doi: 10.1159/000444506. Epub 2016 Apr 14.
4
Clinician's Subjective Experience in the Cross-Cultural Psychiatric Encounter.临床医生在跨文化精神医学遭遇中的主观体验。
Psychopathology. 2020;53(5-6):282-290. doi: 10.1159/000509489. Epub 2020 Sep 3.
5
Reducing diagnostic errors in the emergency department at the time of patient treatment.在患者治疗期间减少急诊科的诊断错误。
Emerg Med Australas. 2023 Jun;35(3):466-473. doi: 10.1111/1742-6723.14146. Epub 2022 Dec 5.
6
Emergency Medicine in the RVH and the challenges it faces from a clinician's perspective.皇家维多利亚医院的急诊医学以及从临床医生角度看它所面临的挑战。
Ulster Med J. 2014 May;83(2):80-5.
7
Whole-Exome Sequencing in the Clinic: Lessons from Six Consecutive Cases from the Clinician's Perspective.临床中的全外显子组测序：从临床医生视角看连续六个病例的经验教训
Mol Syndromol. 2015 Feb;6(1):23-31. doi: 10.1159/000371598. Epub 2015 Feb 3.
8
The Clinician's Subjective Experience during the Interaction with Adolescent Psychiatric Patients: Validity and Reliability of the Assessment of Clinician's Subjective Experience.临床医生与青少年精神科患者互动时的主观体验：临床医生主观体验评估的效度和信度。
Psychopathology. 2021;54(3):119-126. doi: 10.1159/000513769. Epub 2021 Mar 31.
9
Challenges Faced by Pakistani Healthcare System: Clinician's Perspective.巴基斯坦医疗系统面临的挑战：临床医生视角
J Coll Physicians Surg Pak. 2018 Dec;28(12):899-901. doi: 10.29271/jcpsp.2018.12.899.
10
The clinical trials group turns 20: a clinician's perspective.
Anaesth Intensive Care. 2014 Sep;42(5):575-8. doi: 10.1177/0310057X1404200505.
引用本文的文献
1
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.治疗抵抗性抑郁症的新兴药物：机制与挑战视角的综述
Brain Sci. 2025 Feb 6;15(2):161. doi: 10.3390/brainsci15020161.
2
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.关于艾氯胺酮用于难治性抑郁症治疗的事实与误解：一项叙述性临床综述
Front Psychiatry. 2024 May 15;15:1394787. doi: 10.3389/fpsyt.2024.1394787. eCollection 2024.
本文引用的文献
1
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.难治性抑郁症：定义、患病率、检测、管理及研究性干预措施。
World Psychiatry. 2023 Oct;22(3):394-412. doi: 10.1002/wps.21120.
2
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.阿立哌唑辅助治疗重度抑郁症患者：一项随机、双盲、安慰剂对照的3期研究。
Am J Psychiatry. 2023 Mar 1;180(3):241-251. doi: 10.1176/appi.ajp.20220504. Epub 2023 Feb 15.
3
What to Expect When Switching to a Second Antidepressant Medication Following an Ineffective Initial SSRI: A Report From the Randomized Clinical STAR*D Study.在初始 SSRI 治疗无效后改用第二种抗抑郁药时的预期：来自随机临床试验 STAR*D 的报告。
J Clin Psychiatry. 2020 Aug 11;81(5):19m12949. doi: 10.4088/JCP.19m12949.
4
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.灵活剂量依他佐辛鼻喷雾剂联合新起始口服抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机、双盲、活性对照研究。
Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.
5
The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF).抗抑郁治疗抵抗的评估：抗抑郁治疗史表单：简短版（ATHF-SF）的原理。
J Psychiatr Res. 2019 Jun;113:125-136. doi: 10.1016/j.jpsychires.2019.03.021. Epub 2019 Mar 22.
6
A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method.一种量化抑郁症治疗抵抗性的多维工具：莫兹利分期法。
J Clin Psychiatry. 2009 Feb;70(2):177-84. doi: 10.4088/jcp.08m04309. Epub 2009 Jan 27.
7
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.第二代抗抑郁药治疗重度抑郁症复发和再发的荟萃分析。
Psychiatr Serv. 2008 Oct;59(10):1121-30. doi: 10.1176/ps.2008.59.10.1121.
8
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.需要一个或多个治疗步骤的抑郁症门诊患者的急性和长期转归：STAR*D报告
Am J Psychiatry. 2006 Nov;163(11):1905-17. doi: 10.1176/ajp.2006.163.11.1905.
9
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.在STAR*D研究中采用基于测量的护理评估西酞普兰治疗抑郁症的疗效：对临床实践的启示
Am J Psychiatry. 2006 Jan;163(1):28-40. doi: 10.1176/appi.ajp.163.1.28.
Zotero 插件